Rationale for adjunctive therapies targeting inflammation pathobiology based phenotypes in pediatric sepsis; from Meningococcemia/atypical Hemolytic Uremic Syndrome, to H1N1 Influenza/Methicillin Resistant Staphylococcus Aureus, to Critical Pertussis, to Epstein Barr Virus Lymphoproliferative Disease, to Ebola and other Viral Hemorrhagic Fevers

Adjunctive therapies have been proposed for use in at least 5 inflammation pathobiology phenotypes in pediatric sepsis-induced multiple organ failure (MOF). Here, we provide host-pathogen interaction prototypes to facilitate understanding of the rationale for personalized therapy in these phenotypes...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Pediatr Clin North Am
Asıl Yazarlar: Podd, Bradley S., Simon, Dennis W., Lopez, Santiago, Nowalk, Andrew, Aneja, Rajesh, Carcillo, Joseph A.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2017
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5663307/
https://ncbi.nlm.nih.gov/pubmed/28941536
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pcl.2017.06.007
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller